Berlin Heart's paediatric LVAD (left-ventricular assist device) in "record-breaking" UK recovery success:
This article was originally published in Clinica
Executive Summary
Berlin Heart has hit the UK headlines with the successful use of an external cardiac-assist device for what is claimed to be a record-breaking time. After the 8-month baby was given the go-ahead to remove life-support due to the severity of a myocarditis-induced heart attack, the Freeman Hospital, in Newcastle, still decided to use Berlin's EXCOR Pediatric left-ventricular assist device (LVAD) as a bridge to transplant, with an outside chance of success. After 120 days supported by the LVAD, followed by a fortnight's recovery, the now 13-month old has left hospital. The Berlin, Germany company is wholly-owned by long-term medtech investment company Syscore, since October 2006.
You may also be interested in...
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.
More Heartmate Troubles For Abbott. Latest Recall Includes 14 Deaths
Abbott initiated a recall in February of thousands of Heartmate devices due to a system obstruction that can result in serious health outcomes, including death. The FDA has now designated the recall as class I.